XTB group in 2024 registered EUR435.3 million, up 21.8%, and EUR199.7 million net profit, 14.3% above the 2023 level, supported by rising client numbers and expansion of investment offering.
Romanians bought medicines worth RON34 billion (EUR6.86 billion) last year, 13.8% more than in 2023, as prescription drugs in pharmacies totaled RON20.8 billion (up 14.2%) and OTC ones RON8 billion, up 6.2%, in line with a report by consultancy company Cegedim.